DNAnexus, Inc.
20 Florence Street
Suite 210
Palo Alto
California
94301
United States
Website: https://dnanexus.com/
70 articles about DNAnexus, Inc.
-
DNAnexus and Curio Bioscience Announce Collaboration to Streamline and Simplify Data Analysis for Large-Scale Spatial Transcriptomics Projects
2/21/2024
DNAnexus, Inc. and Curio Bioscience today announced a collaboration to streamline and simplify data analysis for high-resolution, whole transcriptome spatial mapping studies.
-
DNAnexus and TMA Precision Health Join Forces to Improve Diagnostics and Treatment Options for Rare Diseases
1/23/2024
DNAnexus, Inc. , the provider of the Precision Health Data Cloud, and TMA Precision Health today announced a collaboration to advance basic and translational research for patients who have a rare disease.
-
DNAnexus and Intelliseq Combine Efforts to Add Automated Genomic Variant Interpretation and Clinical Reporting Capabilities to Precision Health Data Cloud
1/11/2024
DNAnexus, Inc. today announced a partnership to simplify and accelerate variant interpretation and clinical reporting.
-
DNAnexus and Discovery Life Sciences to Streamline Precision Health Data Analysis
12/13/2023
DNAnexus, Inc., the provider of the Precision Health Data Cloud, and Discovery Life Sciences, the Biospecimen and Biomarker Specialists, announced a collaboration to help streamline Discovery’s next-generation sequencing data analysis.
-
DNAnexus Announces Appointment of Thomas Laur as CEO
9/12/2023
DNAnexus Inc., the leading provider of cloud-based genomic and biomedical data management and analysis software, announced that Thomas Laur has been appointed Chief Executive Officer and member of the company’s Board of Directors, effective September 11, 2023.
-
DNAnexus and BigOmics Analytics Join Forces to Improve Proteomics and Transcriptomics Data Visualization and Interpretation
8/2/2023
Complete collaborative environment with intuitive interface addresses common analysis challenges to help accelerate transition from scientific discovery to data-driven precision medicine.
-
Fore Genomics Adopts DNAnexus Platform to Access and Analyze Whole-Genome Newborn Screening Data
7/25/2023
DNAnexus Inc. today announced that Fore Genomics, a proactive genetic testing company designed for healthy newborns, infants, and children, is using the DNAnexus platform for its FORESITE 360 test.
-
DNAnexus Platform Enables Researchers to Access and Analyze Biomedical Data for Largest Health Research Program in Mexico
6/27/2023
DNAnexus Inc. today announced its platform is being used by researchers to access and analyze data from the Mexico City Prospective Study, the largest population health research study of its kind in Mexico.
-
DNAnexus Adds Jeff Margolis to Board of Directors
10/21/2022
DNAnexus, Inc., the leader in biomedical informatics and data management, announced the appointment of Jeff Margolis, a seasoned healthcare information technology executive and current Senior Advisor for Blackstone, to its Board of Directors.
-
DNAnexus Appoints Chief Commercial Officer to Accelerate Global Adoption of Leading Biomedical Data-Driven Technology Platform
9/20/2022
DNAnexus, Inc., the leading provider of cloud-based genomic and biomedical data access and companion analysis software, today announced the appointment of Stephen Nuckols as Chief Commercial Officer.
-
DNAnexus Selected as Platform Provider of the Trusted Research Environment for UK’s Largest Health Research Program
9/12/2022
DNAnexus, Inc., the leading provider of cloud-based genomic and biomedical data access and companion analysis software, announced that it has been awarded a three-year contract by Our Future Health.
-
DNAnexus and Twist Bioscience Collaborate to Provide Data Analysis Software for NGS Workflow
7/13/2022
Collaboration integrates DNAnexus’ proven biomedical data analysis platform with Twist’s NGS Methylation Detection and Unique Molecular Identifier Adapter Systems.
-
Money on the Move: March 9-15
3/16/2022
The companies that got money this week were the ones investing in ambitious, future-looking technologies, such as RNA genomics, biochips and antibody-drug conjugates. -
New Benchmark Report from NIST, Baylor College of Medicine and DNAnexus Helps Provide Accurate Identification of Variants in Challenging Medically Relevant Genes
2/8/2022
Researchers from National Institute of Standards and Technology, Baylor College of Medicine and DNAnexus, Inc., together with other members of the Genome in a Bottle consortium, announce the publication of a comprehensive benchmark dataset comprising 273 challenging medically relevant autosomal genes that are associated with the development of diseases such as homocystinuria and spinal muscular atrophy.
-
DNAnexus Strengthens Leadership Team with Appointment of Dr. Asha S. Collins as General Manager of Biobanks
9/8/2021
DNAnexus, Inc. today announced the appointment of Asha S. Collins, PhD, to General Manager, Biobanks.
-
DNAnexus Promotes Dr. Fan Fan to Chief Product Officer
3/30/2021
DNAnexus, Inc. , the leading cloud-based SaaS company serving the global Healthcare and Life Sciences community, today announced the promotion of Fan Fan, Ph.D., to Chief Product Officer.
-
DNAnexus Completes $100 Million Financing
6/9/2020
Supporting the company’s global biomedical data and informatics platform and expansion in clinical diagnostics, pharmaceuticals, and medical centers
-
FDA Awards DNAnexus with Five-Year, $20 Million Contract to Power precisionFDA Collaborative Omics Environment in the Cloud
12/3/2019
DNAnexus’ FedRAMP-authorized cloud-based platform exemplifies FDA strategy for enhancing the regulatory process through data, technology, and stakeholder engagement.
-
DNAnexus Appoints Scott Gibson as Chief Financial Officer
5/20/2019
Experienced senior leader brings blend of strategic and operational skills to support company’s continued growth
-
DNAnexus Appoints David Fenstermacher as Vice President of Precision Medicine and Data Sciences
5/20/2019
Former MedImumune executive hired to grow company’s precision health initiatives and drug discovery programs